PlainRecalls
FDA Drug Moderate Class II Terminated

Cidofovir injection 375 mg/mL (75 mg/mL) vial Injection, 5 mL vials, Rx Only, Mfg. By Emcure Pharmaceutical Ltd Hinjawadi, Pune, India, Mfg for: Heritage Pharmaceuticals Inc. UPC 323155216388, NDC 23155-216-31

Reported: October 31, 2018 Initiated: October 15, 2018 #D-0094-2019

Product Description

Cidofovir injection 375 mg/mL (75 mg/mL) vial Injection, 5 mL vials, Rx Only, Mfg. By Emcure Pharmaceutical Ltd Hinjawadi, Pune, India, Mfg for: Heritage Pharmaceuticals Inc. UPC 323155216388, NDC 23155-216-31

Reason for Recall

Lack of Assurance of Sterility: complaints received about dried powder on the outside of the bottle

Details

Units Affected
2,789 Units
Distribution
Nationwide within the United States
Location
East Brunswick, NJ

Frequently Asked Questions

What product was recalled?
Cidofovir injection 375 mg/mL (75 mg/mL) vial Injection, 5 mL vials, Rx Only, Mfg. By Emcure Pharmaceutical Ltd Hinjawadi, Pune, India, Mfg for: Heritage Pharmaceuticals Inc. UPC 323155216388, NDC 23155-216-31. Recalled by Heritage Pharmaceuticals, Inc.. Units affected: 2,789 Units.
Why was this product recalled?
Lack of Assurance of Sterility: complaints received about dried powder on the outside of the bottle
Which agency issued this recall?
This recall was issued by the FDA Drug on October 31, 2018. Severity: Moderate. Recall number: D-0094-2019.